Digital-First Scale-Up in Cell & Gene Therapy 

In an article published by Contract Pharma, Project Farma CEO Anshul Mangal shares why scaling cell and gene therapies is increasingly a digital challenge as much as a scientific one. As programs move from early development toward commercialization, he outlines how gaps in data connectivity, process visibility, and system integration can create risk across manufacturing, quality, and supply chain operations. 

The article explores how a digital-first foundation, spanning automation, analytics, and end-to-end data integrity, can help strengthen process control, support regulatory readiness, and build more resilient, scalable manufacturing models for advanced therapies. 

Click here to read, ‘Improving Cell and Gene Therapy Scale-Up with a Digital-First Approach’.